CLINICAL_TRIALS
trial_result
· 2017-06-14
Clinical Trial Update: Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma [Phase 2]
Summary
Phase II trial of BKM120 in recurrent glioblastoma has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Patrick Y. Wen, MD | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14